- Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CE…
Number of the records: 1  

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

  1. TitleCetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial / J. Ocvirk ... [et al.]
    Another responsib. Ocvirk, J. (Author)
    Brodowicz, T. (Author)
    Wrba, F. (Author)
    Ciuleanu, T. E. (Author)
    Kurteva, G. (Author)
    Beslija, S. (Author)
    Koza, Ivan, 1940-2021 (Author)
    Pápai, Z. (Author)
    Messinger, D. (Author)
    Yilmaz, U. (Author)
    Faluhelyi, Z. (Author)
    Yalcin, Suayib (Author)
    Papamichael, D. (Author)
    Wenczl, M. (Author)
    Mrsic-Krmpotic, Z. (Author)
    Shacham-Shmueli, E. (Author)
    Vrbanec, D. (Author)
    Esser, R. (Author)
    Scheithauer, W. (Author)
    Zielinski, C. C. (Author)
    Translated titleCetuximab plus FOLFOX6 alebo FOLFIRI pri metastatickom karcinóme kolorekta: štúdia CECOG
    NoteWorld J Gastroenterol. 2010 Jul 7, 16(25): 3133-43
    In Onkológia. -- ISSN 1336-8176. -- Roč. 6, č. 1 (2011), s. 56
    Call numberC 3069
    MeSH Subject nádory kolorektálne - farmakoterapia
    farmakoterapia kombinovaná
    cytostatiká - použitie terapeutické
    fluorouracil
    kyselina listová
    prežívanie bez choroby
    skúšanie randomizované kontrolované ako téma
    Keywords cetuximab * oxaliplatina
    Form, Genre abstrakt v angličtine
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.